(Q43273313)

18 November 2017

title

Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)? (English)

1 reference

18 November 2017

1 reference

1 reference

7

Xu Shen

1 reference

18 November 2017

Kunqian Yu

1

1 reference

18 November 2017

Cheng Luo

2

1 reference

18 November 2017

Guangrong Qin

3

1 reference

18 November 2017

Zhijian Xu

4

1 reference

18 November 2017

Ning Li

5

1 reference

18 November 2017

Hong Liu

6

1 reference

18 November 2017

Jianpeng Ma

8

1 reference

18 November 2017

Qinghua Wang

9

1 reference

18 November 2017

Caiguang Yang

10

1 reference

18 November 2017

Weiliang Zhu

11

1 reference

18 November 2017

Hualiang Jiang

12

1 reference

18 November 2017

publication date

22 September 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

19

1 reference

18 November 2017

issue

10

1 reference

18 November 2017

page(s)

1221-1224

1 reference

An overview of the epidemiology of avian influenza

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Influenza viruses and the evolution of avian influenza virus H5N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Characterization of the 1918 influenza virus polymerase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

'Flu' and structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.111

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CR.2009.111

1 reference

Dimensions Publication ID

18 November 2017

1027540769

0 references

1 reference